PolyTherics

About:

PolyTherics provides a range of technologies and services to develop biomedical polymers for therapeutic applications.

Top Investors: Invesco, Mercia Fund Managers, Imperial Innovations, Capital Fund Management, Longbow Capital

Description:

PolyTherics has focused on technology development in the area of biomedical polymers for therapeutic applications. The most advanced of its techniques, site-specific PEGylation or TheraPEG, is being exploited in partnership with companies developing biopharmaceuticals. PolyTherics is also committed to developing its own pipeline of optimised clinical candidates.

Total Funding Amount:

$33.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2001-01-01

Contact Email:

info(AT)polytherics.co.uk

Founders:

Steve Brocchini, Sunil Shaunak

Number of Employees:

11-50

Last Funding Date:

2013-07-26

IPO Status:

Private

Industries: